Quick Takeaways
- Ikarian Capital, LLC filed SCHEDULE 13G/A for Avenue Therapeutics, Inc. Common Stock (ATXI).
- Disclosed ownership: 4.1%.
- Date of event: 31 Dec 2025.
Ikarian Capital, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Avenue Therapeutics, Inc. Common Stock (ATXI)
- Filing Manager
- Ikarian Capital, LLC
- Reporting Manager
- Ikarian Capital, LLC
- Symbol
- ATXI
- Shares outstanding
- 3,190,732 shares
- Disclosed Ownership
- 130,820 shares
- Ownership
- 4.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 17:09:07 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Ikarian Capital, LLC disclosed 4.1% ownership in Avenue Therapeutics, Inc. Common Stock (ATXI) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 17 Feb 2026, 17:09.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Ikarian Capital, LLC | 4.1% | 130,820 | 0 | 130,820 | /s/ Neil Shahrestani | Neil Shahrestani, Sole Manager | |
| Neil Shahrestani | 4.1% | 130,820 | 0 | 130,820 | /s/ Neil Shahrestani | Neil Shahrestani |